ROLE OF ANGIOTENSIN CONVERTING ENZYMES ACE AND ACE2 IN DIABETES INDUCED CARDIOVASCULAR DYSFUNCTION

ROLE OF ANGIOTENSIN CONVERTING ENZYMES ACE AND ACE2 IN DIABETES INDUCED CARDIOVASCULAR DYSFUNCTION

Bibliographic Details
Main Author:	Kanakamedala, Keerthy
Language:	English
Published:	Wright State University / OhioLINK 2007
Subjects:	db/db mice ACE ACE2 Angiotensin
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=wright1196272791

Similar Items

Synthesis of angiotensin-converting enzyme (ACE) inhibitors: an important class of antihypertensive drugs
by: Lima Dênis Pires de
Published: (1999-01-01)

Role of Angiotensin-Converting Enzyme (ACE) gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction
by: Nagaraja Moorthy, et al.
Published: (2021-02-01)

The Role of Angiotensin Converting Enzyme (ACE) 2 in a Murine Model of Insulin Resistance and Albuminuria
by: Weir, Nathan Michael
Published: (2012)

Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? – A systematic review
by: Perna Annalisa, et al.
Published: (2005-10-01)

Genetic Variability Associated with Angiotensin Converting Enzyme (ACE) Gene Polymorphism in Sportsmen Pursuing Different Sports
by: Paulauskas Algimantas, et al.
Published: (2009-01-01)

Study of angiotensin converting enzyme (ACE) inhibitory effects of main Papaver spp. alkaloids
by: SA Ziai, et al.
Published: (2004-02-01)

Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2020-09-01)

Corrigendum: Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
by: Sonia Tamanna, et al.
Published: (2021-05-01)

Chymase inhibition retards albuminuria in type 2 diabetes
by: Benjamin J. Bivona, et al.
Published: (2019-12-01)

The angiotensin converting enzyme (ace) gene polymorphism: Insight study of the renal regulation of the arterial blood pressure
by: Durmić Tijana, et al.
Published: (2016-01-01)

Treatment and Management of Hypertension by Targeting ACE Inhibitors: in silico Approach
by: Seema Bawa, et al.
Published: (2019-03-01)

Physical exercise training but not metformin attenuates albuminuria and shedding of ACE2 in type 2 diabetic db/db mice
by: Somineni, Hari Krishna
Published: (2013)

Alu insertion/deletion of ACE gene polymorphism might not affect significantly the serum bradykinin level in hypertensive patients taking ACE inhibitors
by: Widodo, et al.
Published: (2017-04-01)

Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
by: Qiyue Ding, et al.
Published: (2021-02-01)

Impact of Diabetes on ACE/ACE2 Balance and Angiotensin II Type 1 Receptor Expression in db/db Diabetic Mice
by: Madhu, Malav Navinchandra
Published: (2009)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

ACE2, the Counter-Regulatory Renin–Angiotensin System Axis and COVID-19 Severity
by: Filippos Triposkiadis, et al.
Published: (2021-08-01)

Probing Angiotensin Converting Enzyme (ACE) Domain-Dependent Inhibition of Onopordia, Isolated from Onopordon acanthium L., Using a Continuous Fluorescent Assay
by: Niusha Sharifi, et al.
Published: (2018-03-01)

The Comparative Value of Serum Angiotensin Converting Enzyme (ACE) and Lysozyme and the use of Polyclonal Antibody Activation in the Work-up of Ocular Sarcoidosis
by: Ioannis Papasavvas, et al.
Published: (2021-03-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

Lemon Extract Reduces Angiotensin Converting Enzyme (ACE) Expression and Activity and Increases Insulin Sensitivity and Lipolysis in Mouse Adipocytes
by: Shilpa Tejpal, et al.
Published: (2020-08-01)

Update on the Angiotensin Converting Enzyme 2-Angiotensin (1-7)-Mas Receptor Axis: Fetal Programming, Sex Differences and Intracellular Pathways
by: Mark C. Chappell, et al.
Published: (2014-01-01)

Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies
by: Murtala Bello Abubakar, et al.
Published: (2021-05-01)

Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
by: Dejan Marčetić, et al.
Published: (2021-07-01)

Characterization of angiotensin-converting enzymes 1 and 2 in the soleus and plantaris muscles of rats
by: T. Fernandes, et al.
Published: (2010-09-01)

Angiotensin Converting Enzyme (ACE): A Marker for Personalized Feedback on Dieting
by: Shilpa Tejpal, et al.
Published: (2020-02-01)

Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart
by: Viktor Bánhegyi, et al.
Published: (2021-07-01)

ROLE OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) IN OBESITY-ASSOCIATED HYPERTENSION
by: Gupte, Manisha
Published: (2011)

The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
by: Craig Steven McLachlan
Published: (2020-07-01)

Podocyte-specific Overexpression of Human Angiotensin-converting Enzyme 2 Attenuates Diabetic Nephropathy in Mice
by: Bose, Renisha Padmini
Published: (2013)

Podocyte-specific Overexpression of Human Angiotensin-converting Enzyme 2 Attenuates Diabetic Nephropathy in Mice
by: Bose, Renisha Padmini
Published: (2013)

Podocyte-specific Overexpression of Human Angiotensin-converting Enzyme 2 Attenuates Diabetic Nephropathy in Mice
by: Bose, Renisha Padmini
Published: (2013)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
by: Ikram Omar Osman, et al.
Published: (2021-06-01)

Endothelium a new target for a therapeutic action of ACE inhibitors
by: Yu A Karpov
Published: (2004-06-01)

Eucalyptol Inhibits Amyloid-β-Induced Barrier Dysfunction in Glucose-Exposed Retinal Pigment Epithelial Cells and Diabetic Eyes
by: Dong Yeon Kim, et al.
Published: (2020-10-01)

ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients
by: David S. Weisman, et al.
Published: (2020-01-01)

Role of ACE 2 and Vitamin D: The Two Players in Global Fight against COVID-19 Pandemic
by: Tapan Behl, et al.
Published: (2021-06-01)

A systematic review of the blood pressure lowering efficacy of ACE inhibitors and angiotensin receptor blockers for primary hypertension
by: Heran, Balraj Singh
Published: (2008)

A systematic review of the blood pressure lowering efficacy of ACE inhibitors and angiotensin receptor blockers for primary hypertension
by: Heran, Balraj Singh
Published: (2008)

A systematic review of the blood pressure lowering efficacy of ACE inhibitors and angiotensin receptor blockers for primary hypertension
by: Heran, Balraj Singh
Published: (2008)